
Series B · Remedy Robotics
Remedy Robotics raises $62M to take its remote stroke-procedure robot toward a pivotal trial
DCVC led the Series B for the San Francisco company, whose N1 System is built to run endovascular procedures on-site, remotely or autonomously. The money funds a planned pivotal trial across the University of California network.





